GermanyTuberculosis profile
Population  2014 81 million
Estimates of TB burden * 2014 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.33 (0.32–0.33) 0.4 (0.4–0.41)
Mortality (HIV+TB only) 0.011 (<0.01–0.015) 0.01 (0.01–0.02)
Prevalence  (includes HIV+TB) 6.3 (2.6–11) 7.8 (3.3–14)
Incidence  (includes HIV+TB) 5 (4.3–5.6) 6.2 (5.4–7)
Incidence (HIV+TB only) 0.12 (0.095–0.15) 0.15 (0.12–0.19)
         
Case detection, all forms (%) 87 (77–100)    
Estimates of MDR-TB burden * 2014   New   Retreatment
% of TB cases with MDR-TB 2.9 (1.3–5.7) 17 (11–25)
MDR-TB cases among notified pulmonary
TB cases
93 (40–180) 47 (31–69)
TB case notifications 2014 New ** Relapse
Pulmonary, bacteriologically confirmed 2 621   90
Pulmonary, clinically diagnosed 550   24
Extrapulmonary 1 015   28
       
Total new and relapse 4 328    
Previously treated, excluding relapses 160    
Total cases notified 4 488    
Among 4 322 new and relapse cases:
146 (3%) cases aged under 15 years; male:female ratio: 1.7
Reported cases of RR-/MDR-TB 2014 New Retreatment Total **
Cases tested for RR-/MDR-TB 273 (10%) 127 (42%) 2 299
Laboratory-confirmed RR-/MDR-TB cases     90
Patients started on MDR-TB treatment ***      
TB/HIV 2014 Number (%)
TB patients with known HIV status    
HIV-positive TB patients    
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART)    
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Treatment success rate and cohort size (%) Cohort
New and relapse cases registered in 2013 (67) 4 029
Previously treated cases, excluding relapse, registered in 2013 (60) 192
HIV-positive TB cases, all types, registered in 2013    
RR-/MDR-TB cases started on second-line treatment in 2012 (47) 60
XDR-TB cases started on second-line treatment in 2012   0
Laboratories 2014  
Is second-line drug susceptibility testing available? Yes, in country
Financing TB control 2015  
National TB programme budget (US$ millions)  
* Ranges represent uncertainty intervals
** Includes cases with unknown previous TB treatment history
*** Includes patients diagnosed before 2014 and patients who were not laboratory-confirmed as having
RR-/MDR-TB
***
(Rate per 100 000 population per year)
Mortality graph
   Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
   Prevalence

(Rate per 100 000 population per year)
Incidence graph
   Notified (new and relapse)   Incidence
   Incidence (HIV+TB only)

(Number of patients)
CPT ART graph
   HIV-positive TB patients
   on CPT   on ART

Treatment success rate (%)
tx success graph
   New   Retreatment
   New and relapse   Retreatment, excluding
relapse
   HIV-positive   RR-/MDR-TB   XDR-TB

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 Generated: 2016-07-27 Data: www.who.int/tb/data